Rekvina Laboratories Share Price | Rekvina Laboratories Stock Screener
VINRKLB
Pharmaceuticals
Share Price BSE
₹33.35
▼
-0.65 (-1.91%)
As of July 2, 2026, the Rekvina Laboratories share price (BSE: VINRKLB) is ₹33.35, down 1.91% from the previous close, with shares trading between ₹33.35 and ₹33.52, and a 52-week range of ₹7.08–₹46.00.
Analyse VINRKLB price movement history and track historical price performance.
Use the Rekvina Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Rekvina Laboratories Market Cap
₹21.40 Cr.
VINRKLB P/E Ratio (TTM)
-84.52
Rekvina Laboratories P/B Ratio
-17.45
EPS (TTM)
₹-0.42
Dividend Yield
-
Debt to Equity
-
VINRKLB 52 Week High
₹46.00
Rekvina Laboratories 52 Week Low
₹7.08
Operating Margin
-20.00%
Profit Margin
-
VINRKLB Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
₹1.00
Total Equity
₹-1.00
Rekvina Laboratories Share Price Chart
Screen Rekvina Laboratories share price with an interactive chart. Analyse VINRKLB price trends and volatility across different timeframes.
Rekvina Laboratories Company Profile - Fundamental Screener
Screen Rekvina Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VINRKLB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE092O01028
Rekvina Laboratories Balance Sheet Screener
Screen VINRKLB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Current Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | -4 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 |
Rekvina Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Rekvina Laboratories income statement and profit fundamentals.
Analyze VINRKLB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Rekvina Laboratories share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -20.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -90.00% | 15.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -0.42 | -0.23 | -0.03 | 0.00 | -0.13 | -0.11 | 0.00 | -0.13 | -0.03 | -0.09 | 0.01 |
Rekvina Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen VINRKLB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Rekvina Laboratories Shareholding Pattern Screener
See Rekvina Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Rekvina Laboratories promoter holding and ownership changes for VINRKLB on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 41.30% | 41.30% | 41.30% | 41.30% | 41.30% | 41.30% | 41.30% | 41.30% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.88% | 45.99% | 45.99% | 45.96% | 44.08% | 47.58% | 51.97% | 51.97% |
| Other Holding | 12.82% | 12.71% | 12.71% | 12.74% | 14.62% | 11.12% | 6.74% | 6.74% |
| Shareholder Count | 2,475 | 503 | 2,427 | 2,426 | 2,427 | 2,430 | 2,430 | 2,431 |
Rekvina Laboratories Share Dividend Screener - Share Yield Analysis
Check Rekvina Laboratories dividend history with payout and yield data.
View Rekvina Laboratories dividend details including ex-dates and amounts for VINRKLB stock.
Rekvina Laboratories Stock Index Membership
See which indices include Rekvina Laboratories stock.
Check VINRKLB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Rekvina Laboratories Market Events Screener - Corporate Actions
Get Rekvina Laboratories corporate actions including splits, bonuses, and buybacks.
Check Rekvina Laboratories stock events that may affect VINRKLB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.00% | ||
| Annual General Meeting | NA | 0.00% | ||
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | -14.23% |
| 2026-04-10 | 2026-04-10 | Extraordinary General Meeting | NA | 31.26% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 61.52% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.00% |
| 2025-01-20 | 2025-01-20 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-08-12 | 2024-08-12 | Annual General Meeting | NA | 0.00% |
Rekvina Laboratories Competitors Screener - Peer Comparison
Screen VINRKLB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 453,474 | 38.82 | 58,220 | 6.38% | 11,565 | 62.37 |
| Divis Laboratories | 178,435 | 69.38 | 10,560 | 8.73% | 2,520 | 52.31 |
| Torrent Pharmaceuticals | 155,641 | 71.51 | 13,886 | 20.34% | 2,138 | 56.90 |
| Cipla | 119,632 | 30.13 | 29,045 | 2.24% | 3,870 | 65.46 |
| Dr Reddys Laboratories | 117,451 | 27.10 | 33,593 | -0.44% | 3,998 | 69.37 |
| Zydus Life Science | 112,225 | 21.63 | 26,720 | 13.65% | 5,242 | 61.62 |
| Lupin | 109,617 | 20.00 | 27,488 | 19.98% | 5,345 | 58.20 |
| Mankind Pharma | 103,527 | 52.44 | 14,278 | 12.03% | 1,750 | 57.08 |
| Aurobindo Pharma | 91,790 | 25.78 | 33,385 | 3.21% | 3,376 | 67.06 |
| Laurus Labs | 79,726 | 88.02 | 6,868 | 22.01% | 890 | 64.65 |
Rekvina Laboratories Company Announcements - News Screener
Screen VINRKLB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Updates on Open Offer | - |
| 2026-07-03 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | - |
| 2026-07-02 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | - |
| 2026-07-01 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | - |
| 2026-07-01 | Letter of Offer | - |
| 2026-05-21 | Financial Results For Quarter Ended & Year Ended On March 31 2026. | - |
| 2026-05-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May 2026 | - |
| 2026-05-18 | Board Meeting Intimation for Consider And Approve Financial Result For The QTR 4 | - |
| 2026-04-10 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-10 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-04-06 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-02 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | - |
| 2026-04-02 | Draft Letter of Offer | - |
| 2026-03-24 | Announcement under Regulation 30 (LODR)-Open Offer - Updates | - |
| 2026-03-24 | Detailed Public Statement | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-18 | Shareholders Meeting -EGM 10.04.2026 | - |
| 2026-03-17 | Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer | - |
| 2026-03-16 | Open Offer | - |